All In Biotech

Drug Trial Radar · NCT04628767

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

A Phase II/III Trial of Durvalumab and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 131 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

131

Planned (sponsor's estimate)

Start

Nov 12, 2021

Primary completion

Sep 30, 2027

Study completion Sep 30, 2027

Sponsor

Sponsor type
NIH
First posted
Nov 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.

Conditions

  • Renal Pelvis and Ureter Urothelial Carcinoma

Interventions

  • Biopsy ProcedureProcedure

    Undergo tissue biopsy

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • CisplatinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT

  • Doxorubicin HydrochlorideDrug

    Given Iv

  • DurvalumabBiological

    Given IV

  • Gemcitabine HydrochlorideDrug

    Given IV

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • MethotrexateDrug

    Given IV

  • PegfilgrastimBiological

    Given via injection

  • Therapeutic Conventional SurgeryProcedure

    Undergo surgery

  • Vinblastine SulfateDrug

    Given Iv

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-free survival (EFS) (Cisplatin eligible cohort: Arms A and B)Time frame: From registration/randomization to the earliest of systemic recurrence outside urinary tract, cancer progression, or death from any cause, assessed up to 5 years
  2. Pathologic complete response (pCR) (Cisplatin ineligible cohort: Arm C)Time frame: At surgery

Locations

259 sites in 1 country. Site status is shown where the registry gives one.

  • Kingman Regional Medical Center

    Kingman, Arizona · Recruiting

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Suspended

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Active not recruiting

  • Sutter Auburn Faith Hospital

    Auburn, California · Active not recruiting

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California · Active not recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Active not recruiting

  • Palo Alto Medical Foundation-Fremont

    Fremont, California · Active not recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • Memorial Medical Center

    Modesto, California · Active not recruiting

  • Palo Alto Medical Foundation-Camino Division

    Mountain View, California · Active not recruiting

  • Palo Alto Medical Foundation Health Care

    Palo Alto, California · Active not recruiting

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California · Recruiting

  • Sutter Roseville Medical Center

    Roseville, California · Active not recruiting

  • Sutter Medical Center Sacramento

    Sacramento, California · Active not recruiting

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • California Pacific Medical Center-Pacific Campus

    San Francisco, California · Active not recruiting

  • Palo Alto Medical Foundation-Santa Cruz

    Santa Cruz, California · Active not recruiting

  • Sutter Pacific Medical Foundation

    Santa Rosa, California · Active not recruiting

  • Palo Alto Medical Foundation-Sunnyvale

    Sunnyvale, California · Active not recruiting

  • Sutter Solano Medical Center/Cancer Center

    Vallejo, California · Active not recruiting

  • UCHealth University of Colorado Hospital

    Aurora, Colorado · Recruiting

  • UCHealth - Cherry Creek

    Denver, Colorado · Suspended

  • Poudre Valley Hospital

    Fort Collins, Colorado · Recruiting

  • Cancer Care and Hematology-Fort Collins

    Fort Collins, Colorado · Recruiting

  • UCHealth Greeley Hospital

    Greeley, Colorado · Recruiting

  • UCHealth Highlands Ranch Hospital

    Highlands Ranch, Colorado · Recruiting

  • UCHealth Lone Tree Health Center

    Lone Tree, Colorado · Recruiting

  • Medical Center of the Rockies

    Loveland, Colorado · Recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Recruiting

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic in Florida

    Jacksonville, Florida · Active not recruiting

  • Emory University Hospital Midtown

    Atlanta, Georgia · Recruiting

  • Emory University Hospital/Winship Cancer Institute

    Atlanta, Georgia · Recruiting

  • Emory Saint Joseph's Hospital

    Atlanta, Georgia · Recruiting

  • Emory Decatur Hospital

    Decatur, Georgia · Recruiting

  • Saint Alphonsus Cancer Care Center-Nampa

    Nampa, Idaho · Recruiting

  • OSF Saint Anthony's Health Center

    Alton, Illinois · Suspended

  • Advocate Good Shepherd Hospital

    Barrington, Illinois · Recruiting

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Active not recruiting

  • Loyola Center for Health at Burr Ridge

    Burr Ridge, Illinois · Active not recruiting

Showing 40 of 259 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.